Chevron Corporation (CVX)

NYSEEnergyOil & Gas IntegratedSnapshot 2026-10-15

$224.98+2.58%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Chevron Corporation’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+10.0%

+10% or more+5%0%−5%−10% or less

13.28 → 14.60 EPS · FY ending Dec 31, 2027 · 15 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 15 to 15; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain capital and cost discipline to ensure financial flexibility	A supporting condition in Chevron Corporation's published investment case. The stated target is maintain or improve cost discipline metrics.	Under Pressure	Capital spending or costs rise materially above guidance without offsetting cash flow	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Management achieved $3 billion in annual run-rate structural cost reductions by 2026-Q2, six months ahead of schedule. Capital expenditures increased modestly from $3.7 billion in 2025-Q2 to $4.5 billion in 2026-Q2, reflecting disciplined investment. The trajectory shows delivering on cost discipline and capital control. Delivery assessment Oct 15, 2026
Return at least $6 billion cash to shareholders per quarter	The company returned $6 billion to shareholders in Q1 2026 through dividends and buybacks.	Intact	Quarterly cash returned falls below $5 billion	Required source inputs unavailable Cannot calculate Cash returned to shareholders from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. The company returned $27.1 billion of cash to shareholders in 2025, including $12.1 billion in share repurchases and $12.8 billion in dividends. Quarterly returns ranged from $5.5 billion to $6.9 billion in cash returned. The trajectory is delivering consistent and record-level shareholder returns. Delivery assessment Oct 15, 2026
Free cash flow of at least $16.6 billion in 2026	Free cash flow is strong with a target of $16.6 billion in 2026.	Under Pressure	Free cash flow falls below $14 billion in 2026	Free cash flow: $18.095B FY2026-Q2; GAAP. Published target: >=16.6 USD_BILLIONS. Target period ends 2026-12-31; this observation covers 2026-Q2. Source published Aug 6, 202618,095,000,000 USD · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Production grew from approximately 3.37 million BOE/day in 2025-Q2 to 4.07 million BOE/day in 2026-Q2 (+20%). Free cash flow increased from $6.1 billion in 2025-Q2 to $16.5 billion YTD 2026-Q2. Management's statements and financials show delivering growth in production and free cash flow. Delivery assessment Oct 15, 2026
Worldwide production growth near 15% and U.S. growth near 24% in Q1 2026	Chevron grows production worldwide by 15% and 24% in the U.S.	Under Pressure	Production growth falls below 7% worldwide or 10% in U.S. over next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Production grew from approximately 3.37 million BOE/day in 2025-Q2 to 4.07 million BOE/day in 2026-Q2 (+20%). Free cash flow increased from $6.1 billion in 2025-Q2 to $16.5 billion YTD 2026-Q2. Management's statements and financials show delivering growth in production and free cash flow. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$14.60

$12.36 → $14.60 · observed estimates

FY2027 revenue$220.80B

$206.50B → $220.80B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$12.36	$206,499,174,486	14 / 11
2026-07-25	$12.67	$210,868,078,890	24 / 13
2026-07-26	$12.67	$210,868,078,890	24 / 13
2026-07-27	$12.45	$207,197,974,486	14 / 11
2026-07-28	$12.67	$210,868,078,890	24 / 13
2026-07-29	$12.46	$205,245,517,842	15 / 11
2026-07-30	$12.46	$205,245,517,842	15 / 11
2026-07-31	$12.46	$205,245,517,842	15 / 11
2026-08-01	$12.46	$205,245,517,842	15 / 11
2026-08-02	$12.55	$204,121,451,175	15 / 11
2026-08-03	$12.56	$204,121,451,175	15 / 11
2026-08-04	$12.60	$202,274,531,547	15 / 11
2026-08-05	$12.96	$209,035,681,680	24 / 13
2026-08-06	$12.93	$209,035,681,680	24 / 13
2026-08-07	$12.60	$202,274,531,547	15 / 11
2026-08-08	$12.60	$202,274,531,547	15 / 11
2026-08-09	$12.97	$209,035,681,680	24 / 13
2026-08-10	$12.60	$202,274,531,547	15 / 11
2026-08-11	$12.60	$202,274,531,547	15 / 11
2026-08-12	$12.60	$202,274,531,547	15 / 11
2026-08-13	$12.60	$202,274,531,547	15 / 11
2026-08-14	$12.60	$202,274,531,547	15 / 11
2026-08-15	$12.60	$202,274,531,547	15 / 11
2026-08-16	$12.60	$202,274,531,547	15 / 11
2026-08-17	$12.60	$202,274,531,547	15 / 11
2026-08-18	$12.60	$202,274,531,547	15 / 11
2026-08-19	$12.60	$202,274,531,547	15 / 11
2026-08-20	$13.03	$206,107,862,230	15 / 10
2026-08-21	$13.02	$207,015,207,155	15 / 10
2026-08-22	$13.02	$207,015,207,155	15 / 10
2026-08-23	$13.00	$208,996,473,821	15 / 10
2026-08-24	$13.00	$208,996,473,821	15 / 10
2026-08-25	$13.04	$211,444,407,155	15 / 10
2026-08-26	$13.04	$211,444,407,155	15 / 10
2026-08-27	$13.04	$211,444,407,155	15 / 10
2026-08-28	$13.04	$211,444,407,155	15 / 10
2026-08-29	$13.04	$211,444,407,155	15 / 10
2026-08-30	$13.04	$211,444,407,155	15 / 10
2026-08-31	$13.04	$211,444,407,155	15 / 10
2026-09-01	$13.04	$211,444,407,155	15 / 10
2026-09-02	$13.04	$211,444,407,155	15 / 10
2026-09-03	$13.04	$211,444,407,155	15 / 10
2026-09-04	$13.03	$211,465,340,488	15 / 10
2026-09-05	$13.23	$211,465,340,488	15 / 10
2026-09-06	$13.23	$211,465,340,488	15 / 10
2026-09-07	$13.23	$211,465,340,488	15 / 10
2026-09-08	$13.23	$211,465,340,488	15 / 10
2026-09-09	$13.27	$211,465,340,488	15 / 10
2026-09-10	$13.27	$211,465,340,488	15 / 10
2026-09-11	$13.27	$211,465,340,488	15 / 10
2026-09-12	$13.27	$211,465,340,488	15 / 10
2026-09-13	$13.28	$211,465,340,488	15 / 10
2026-09-14	$13.28	$211,465,340,488	15 / 10
2026-09-15	$13.28	$211,465,340,488	15 / 10
2026-09-16	$13.28	$211,465,340,488	15 / 10
2026-09-17	$13.37	$212,475,312,155	15 / 10
2026-09-18	$13.37	$212,475,312,155	15 / 10
2026-09-19	$13.37	$212,475,312,155	15 / 10
2026-09-20	$13.37	$212,475,312,155	15 / 10
2026-09-21	$13.37	$212,475,312,155	15 / 10
2026-09-22	$13.47	$212,475,312,155	15 / 10
2026-09-23	$13.47	$212,475,312,155	15 / 10
2026-09-24	$13.54	$215,032,778,821	15 / 10
2026-09-25	$13.61	$215,062,178,821	15 / 10
2026-09-26	$13.76	$218,756,018,078	15 / 10
2026-09-27	$13.76	$218,756,018,078	15 / 10
2026-09-28	$13.76	$218,756,018,078	15 / 10
2026-09-29	$14.00	$218,756,018,078	15 / 10
2026-09-30	$14.00	$218,756,018,078	15 / 9
2026-10-01	$14.06	$218,756,018,078	14 / 9
2026-10-02	$14.06	$218,756,018,078	14 / 9
2026-10-03	$14.14	$218,756,018,078	14 / 9
2026-10-04	$14.14	$218,756,018,078	14 / 10
2026-10-05	$14.14	$218,756,018,078	14 / 10
2026-10-06	$14.18	$218,756,018,078	14 / 10
2026-10-07	$14.18	$218,756,018,078	14 / 10
2026-10-08	$14.21	$220,358,618,078	14 / 10
2026-10-09	$14.24	$220,378,897,296	14 / 10
2026-10-10	$14.36	$221,905,030,629	14 / 10
2026-10-11	$14.36	$221,905,030,629	14 / 10
2026-10-12	$14.36	$221,905,030,629	14 / 10
2026-10-13	$14.45	$222,408,763,963	14 / 10
2026-10-14	$14.45	$222,408,763,963	15 / 10
2026-10-15	$14.60	$220,800,297,296	15 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	18	6	1
2026-06-01	18	6	1
2026-07-01	20	5	1
2026-08-01	20	4	1
2026-09-01	20	4	1
2026-10-01	20	4	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 20 Buy / Strong Buy · 4 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades4 maintains

Recent actions · Sep 16–Oct 15 · 4 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Mizuho SecuritiesOct 12 · prior Aug 3

$224.00 → $234.00+4.5%

UBSOct 8 · prior Sep 25

$250.00 → $235.00-6.0%

HSBCSep 25 · prior Sep 25

$250.00 → $90.00-64.0%

$0$137.50$275.00

1 raises · 2 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain capital and cost discipline to ensure financial flexibilityPublished status: Under Pressure
Return at least $6 billion cash to shareholders per quarterRequired source inputs unavailable
Free cash flow of at least $16.6 billion in 2026Published status: Under Pressure
Worldwide production growth near 15% and U.S. growth near 24% in Q1 2026Published status: Under Pressure

Next proof point

Oct 30, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-21.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Chevron Corporation outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on returning cash to shareholders. The current thesis state is cautious, as recent performance has not matched industry peers, but management remains committed to growth and discipline.

What's priced into Chevron Corporation

The market appears to have priced in a low execution quality and a turbulent sector environment, suggesting a justified valuation compared to peers. There is a slight expectations gap, indicating that the market may not fully account for potential positive developments.

What the fundamentals likely do

Fundamentals are likely to remain stable, given management's focus on free cash flow and production growth. However, there is a moderate risk of missing guidance, especially considering recent industry trends.

What Chevron Corporation hinges on

The thesis hinges on several factors, including inflation trends and the performance of sector peers like XOM and SHEL. Additionally, any changes in guidance from management could significantly impact sentiment.